Meike Burger

Freiburg, BW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Retraction notice to "Enhanced AC133-specific CAR T cell therapy induces durable remissions in mice with metastatic small cell lung cancer" [Canc. Lett. 520 (2021) 385-399].

Retraction notice to "Enhanced AC133-specific CAR T cell therapy induces durable remissions in mice with metastatic small cell lung cancer" [Canc. Lett. 520 (2021) 385-399].

Journal: Cancer letters

Published: April 24, 2022

Enhanced AC133-specific CAR T cell therapy induces durable remissions in mice with metastatic small cell lung cancer.

Enhanced AC133-specific CAR T cell therapy induces durable remissions in mice with metastatic small cell lung cancer.

Journal: Cancer letters

Published: March 24, 2022

RETRACTED: Enhanced AC133-specific CAR T cell therapy induces durable remissions in mice with metastatic small cell lung cancer.

RETRACTED: Enhanced AC133-specific CAR T cell therapy induces durable remissions in mice with metastatic small cell lung cancer.

Journal: Cancer letters

Published: April 17, 2021

Microenvironmental stromal cells abrogate NF-κB inhibitor-induced apoptosis in chronic lymphocytic leukemia.

Microenvironmental stromal cells abrogate NF-κB inhibitor-induced apoptosis in chronic lymphocytic leukemia.

Journal: Haematologica

Published: January 26, 2017

CXCR4 antagonists suppress small cell lung cancer progression.

CXCR4 antagonists suppress small cell lung cancer progression.

Journal: Oncotarget

Published: July 25, 2016

An orthotopic mouse model of small cell lung cancer reflects the clinical course in patients.

An orthotopic mouse model of small cell lung cancer reflects the clinical course in patients.

Journal: Clinical & experimental metastasis

Published: April 26, 2016

Spleen Tyrosine Kinase Is Involved in the CD38 Signal Transduction Pathway in Chronic Lymphocytic Leukemia.

Spleen Tyrosine Kinase Is Involved in the CD38 Signal Transduction Pathway in Chronic Lymphocytic Leukemia.

Journal: PloS one

Published: February 26, 2016

Proteasome inhibitor bortezomib enhances the effect of standard chemotherapy in small cell lung cancer.

Proteasome inhibitor bortezomib enhances the effect of standard chemotherapy in small cell lung cancer.

Journal: Oncotarget

Published: January 26, 2016

BCR and chemokine responses upon anti-IgM and anti-IgD stimulation in chronic lymphocytic leukaemia.

BCR and chemokine responses upon anti-IgM and anti-IgD stimulation in chronic lymphocytic leukaemia.

Journal: Annals of hematology

Published: January 18, 2016

PIM kinases are essential for chronic lymphocytic leukemia cell survival (PIM2/3) and CXCR4-mediated microenvironmental interactions (PIM1).

PIM kinases are essential for chronic lymphocytic leukemia cell survival (PIM2/3) and CXCR4-mediated microenvironmental interactions (PIM1).

Journal: Molecular cancer therapeutics

Published: March 25, 2014

Tumor cell heterogeneity in Small Cell Lung Cancer (SCLC): phenotypical and functional differences associated with Epithelial-Mesenchymal Transition (EMT) and DNA methylation changes.

Tumor cell heterogeneity in Small Cell Lung Cancer (SCLC): phenotypical and functional differences associated with Epithelial-Mesenchymal Transition (EMT) and DNA methylation changes.

Journal: PloS one

Published: February 04, 2014

A feeder-free differentiation system identifies autonomously proliferating B cell precursors in human bone marrow.

A feeder-free differentiation system identifies autonomously proliferating B cell precursors in human bone marrow.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: January 01, 2014

Showing 1-12 of 19

Last Updated: 09/26/2026